Sign In
Buy LLY
$1,125.38
+42.15 (+3.89%)
At Close: Jun 04, 2026
Hims & Hers (NYSE: HIMS) Earnings Are In (Live Coverage)
12:05pm, Tuesday, 06'th May 2025
Live Updates Live Coverage Has Ended HIMS forward guidance is exciting 5:02 pm by Joel South HOLY MOLY $HIMS JUST GUIDED TO $6.5B IN 2030 SALES WITH 20% EBITDA MARGINS pic.twitter.com/9w2fDU8rlQ — S
Eli Lilly Stock Slips on Outlook. Is It Time to Buy the Dip?
10:00am, Tuesday, 06'th May 2025
Shares of Eli Lilly (LLY -2.90%) sank after the drugmaker lowered its full-year profit outlook, and a potential headwind to pricing and access to its drug Zepbound emerged. However, the guidance reduc
LLY ACTIVE INVESTIGATION: Contact Levi & Korsinsky if you lost money on your Eli Lilly and Company investment
07:30am, Tuesday, 06'th May 2025
NEW YORK, NY / ACCESS Newswire / May 6, 2025 / Levi & Korsinsky notifies investors that it has commenced an investigation of Eli Lilly and Company ("Eli Lilly") (NYSE:LLY) concerning possible violatio
Trump signs order to boost domestic drug manufacturing as pharma tariff threat looms
04:56pm, Monday, 05'th May 2025
President Donald Trump signed an executive order to incentivize drug manufacturing in the U.S. The order comes ahead of Trump's planned tariffs on pharmaceuticals imported into the U.S.
Lilly declares second-quarter 2025 dividend
12:47pm, Monday, 05'th May 2025
INDIANAPOLIS , May 5, 2025 /PRNewswire/ -- The board of directors of Eli Lilly and Company (NYSE:LLY) has declared a dividend for the second quarter of 2025 of $1.50 per share on outstanding common st
Investors Heavily Search Eli Lilly and Company (LLY): Here is What You Need to Know
10:05am, Monday, 05'th May 2025
Recently, Zacks.com users have been paying close attention to Lilly (LLY). This makes it worthwhile to examine what the stock has in store.
NEW YORK, NY / ACCESS Newswire / May 5, 2025 / Levi & Korsinsky notifies investors that it has commenced an investigation of Eli Lilly and Company ("Eli Lilly") (NYSE:LLY) concerning possible violatio
3 No-Brainer Stocks to Buy in May
06:45am, Monday, 05'th May 2025
Any time is a great time to buy stocks -- if you pick the right stocks. That's true even in May, a month where some investors have traditionally opted to take a break from the stock market for the sum
Is the Trump Administration About to Cause AbbVie, Eli Lilly, and Johnson & Johnson Stocks to Crash?
04:49am, Sunday, 04'th May 2025
Investors often view Pharmaceutical stocks as safe havens during periods of market turbulence. Stock market volatility or even economic downturns usually don't affect drugmakers' underlying businesses
Top 50 High-Quality Dividend Stocks For May 2025
10:39pm, Saturday, 03'rd May 2025
I track 50 high-quality dividend growth stocks to identify opportune investments, updating valuation ratings daily to focus on attractive opportunities. Despite a market sell-off, my investable univer
Eli Lilly's Meltdown Triggers Near Doubling Upside Potential - Reiterate Buy
09:30am, Saturday, 03'rd May 2025
LLY's valuation remains highly attractive post-market overreaction, with the FY2025 bottom-line impact merely attributed to one-time acquired IPR&D expenses from ongoing M&A activities. Despite the ta
Eli Lilly: Don't Overthink This Buying Opportunity
09:00am, Saturday, 03'rd May 2025
Eli Lilly faced a 12% drop due to CVS formulary changes favoring Novo Nordisk, but I explain why this seems overstated. Lilly has gained control as the US market leader for GLP-1 drugs, and is still m
Eli Lilly Stock Offers Buying Opportunity For Goldman Sachs. Concerns Over CVS Setback Are Overblown, Analysts Say
02:50pm, Friday, 02'nd May 2025
Eli Lilly and Co LLY on Thursday reported first-quarter earnings and lowered its 2025 guidance.
Calls of the Day: AutoZone, Roblox, Eli Lilly, Johnson & Johnson and Quanta Services
01:46pm, Friday, 02'nd May 2025
Oppenheimer upgrades AutoZone — NewEdge Wealth CEO Rob Sechan owns it and breaks it down, while the Investment Committee drops their latest picks.
NEW YORK, NY / ACCESS Newswire / May 2, 2025 / Levi & Korsinsky notifies investors that it has commenced an investigation of Eli Lilly and Company ("Eli Lilly") (NYSE:LLY) concerning possible violatio
